Norris Medicines Ltd. - Research Center
524414 NORRIS Group (XT) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Sales | 8.36 | 9.44 | 12.25 | 7.84 | 16.27 |
| Operating profit | 0.92 | -0.07 | -1.74 | -2.16 | -0.61 |
| Interest | 1.50 | 1.48 | 1.63 | 0.88 | 0.73 |
| Gross profit | -0.56 | -1.53 | -3.33 | -2.95 | -1.30 |
| EPS (Rs) | -1.76 | -3.29 | -5.00 | -2.86 | -1.69 |
Annual
results in details
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Other income | 0.01 | 0.03 | 0.05 | 0.09 | 0.04 |
| Stock adjustment | 0.13 | 2.04 | -0.79 | -0.64 | 0.14 |
| Raw material | 3.23 | 3.57 | 9.53 | 5.16 | 10.04 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 2.30 | 2.33 | 3.10 | 3.23 | 3.81 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 1.77 | 1.57 | 2.15 | 2.25 | 2.89 |
| Provisions made | - | - | - | - | - |
| Depreciation | 0.63 | 0.66 | 0.67 | 0.73 | 0.71 |
| Taxation | 0.56 | 1.08 | 0.97 | -0.84 | -0.33 |
| Net profit / loss | -1.75 | -3.26 | -4.96 | -2.84 | -1.68 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 9.93 | 9.93 | 9.93 | 9.93 | 9.93 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 11.04 | -0.76 | -14.21 | -27.48 | -3.77 |
| GPM (%) | -6.73 | -16.14 | -27.04 | -37.23 | -7.96 |
| NPM (%) | -20.89 | -34.48 | -40.34 | -35.83 | -10.28 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis